Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Detection of Proteoforms Using Top-Down Mass Spectrometry and Diagnostic Ions.

Coelho Graça D, Hartmer R, Jabs W, Scherl A, Clerici L, Samii K, Tsybin YO, Hochstrasser D, Lescuyer P.

Methods Mol Biol. 2019;1959:173-183. doi: 10.1007/978-1-4939-9164-8_12.

PMID:
30852823
2.

Accessing Reliable Health Information on the Web: A Review of the HON Approach.

Boyer C, Gaudinat A, Hanbury A, Appel RD, Ball MJ, Carpentier M, van Bemmel JH, Bergmans JP, Hochstrasser D, Lindberg D, Miller R, Peterschmitt JC, Safran C, Thonnet M, Geissbühler A.

Stud Health Technol Inform. 2017;245:1004-1008. Review.

PMID:
29295252
3.

Health On the Net's 20 Years of Transparent and Reliable Health Information.

Boyer C, Appel RD, Ball MJ, van Bemmel JH, Bergmans JP, Carpentier M, Hochstrasser D, Lindberg D, Miller R, Peterschmitt JC, Safran C, Thonnet M, Geissbühler A.

Stud Health Technol Inform. 2016;228:700-4.

PMID:
27577475
4.

Evaluation and identification of dioxin exposure biomarkers in human urine by high-resolution metabolomics, multivariate analysis and in vitro synthesis.

Jeanneret F, Tonoli D, Hochstrasser D, Saurat JH, Sorg O, Boccard J, Rudaz S.

Toxicol Lett. 2016 Jan 5;240(1):22-31. doi: 10.1016/j.toxlet.2015.10.004. Epub 2015 Oct 22.

PMID:
26474838
5.

Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.

Steiner C, Tille JC, Lamerz J, Kux van Geijtenbeek S, McKee TA, Venturi M, Rubbia-Brandt L, Hochstrasser D, Cutler P, Lescuyer P, Ducret A.

Mol Cell Proteomics. 2015 Oct;14(10):2786-99. doi: 10.1074/mcp.O115.049049. Epub 2015 Jul 6.

6.

Steroidomic Footprinting Based on Ultra-High Performance Liquid Chromatography Coupled with Qualitative and Quantitative High-Resolution Mass Spectrometry for the Evaluation of Endocrine Disrupting Chemicals in H295R Cells.

Tonoli D, Fürstenberger C, Boccard J, Hochstrasser D, Jeanneret F, Odermatt A, Rudaz S.

Chem Res Toxicol. 2015 May 18;28(5):955-66. doi: 10.1021/tx5005369. Epub 2015 Apr 17.

PMID:
25826746
7.

Identification of hemoglobin variants by top-down mass spectrometry using selected diagnostic product ions.

Coelho Graça D, Hartmer R, Jabs W, Beris P, Clerici L, Stoermer C, Samii K, Hochstrasser D, Tsybin YO, Scherl A, Lescuyer P.

Anal Bioanal Chem. 2015 Apr;407(10):2837-45. doi: 10.1007/s00216-015-8525-5. Epub 2015 Mar 10.

PMID:
25753013
8.

Assessment of the influence of the patient's inflammatory state on the accuracy of a haptoglobin selected reaction monitoring assay.

Lassout O, Hochstrasser D, Lescuyer P.

Clin Proteomics. 2014 Nov 1;11(1):38. doi: 10.1186/1559-0275-11-38. eCollection 2014.

9.

The magic of words.

Calvete JJ, Bini L, Hochstrasser D, Sanchez JC, Turck N.

J Proteomics. 2014 Jul 31;107:1-4. doi: 10.1016/j.jprot.2014.06.018. No abstract available.

PMID:
25039011
10.

Human urinary biomarkers of dioxin exposure: analysis by metabolomics and biologically driven data dimensionality reduction.

Jeanneret F, Boccard J, Badoud F, Sorg O, Tonoli D, Pelclova D, Vlckova S, Rutledge DN, Samer CF, Hochstrasser D, Saurat JH, Rudaz S.

Toxicol Lett. 2014 Oct 15;230(2):234-43. doi: 10.1016/j.toxlet.2013.10.031. Epub 2013 Nov 4.

PMID:
24201000
11.

Proteomic approach to investigate pathogenicity and metabolism of methicillin-resistant Staphylococcus aureus.

François P, Scherl A, Hochstrasser D, Schrenzel J.

Methods Mol Biol. 2014;1085:231-50. doi: 10.1007/978-1-62703-664-1_14.

PMID:
24085700
12.

Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.

Wullschleger A, Kapina V, Molnarfi N, Courvoisier DS, Seebach JD, Santiago-Raber ML, Hochstrasser DF, Lalive PH.

PLoS One. 2013 Aug 27;8(8):e72399. doi: 10.1371/journal.pone.0072399. eCollection 2013.

13.

The 9th Siena Meeting - from genome to proteome: open innovations.

Bini L, Hochstrasser D, Sanchez JC.

J Proteomics. 2013 Sep 2;90:1-2. doi: 10.1016/j.jprot.2013.07.006. No abstract available.

PMID:
23954032
14.

Quantitative mass spectrometry analysis of intact hemoglobin A2 by precursor ion isolation and detection.

Acosta-Martin AE, Coelho Graça D, Antinori P, Clerici L, Hartmer R, Meyer M, Hochstrasser D, Samii K, Lescuyer P, Scherl A.

Anal Chem. 2013 Aug 20;85(16):7971-5. doi: 10.1021/ac401782t. Epub 2013 Aug 8.

PMID:
23883289
15.

Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.

Farina A, Dumonceau JM, Antinori P, Annessi-Ramseyer I, Frossard JL, Hochstrasser DF, Delhaye M, Lescuyer P.

Biochim Biophys Acta. 2014 May;1844(5):1018-25. doi: 10.1016/j.bbapap.2013.06.010. Epub 2013 Jun 24.

PMID:
23806607
16.

Time-course proteomic analysis of taurocholate-induced necrotizing acute pancreatitis.

Fétaud-Lapierre V, Pastor CM, Jorge-Costa M, Hochstrasser DF, Morel DR, Frossard JL, Lescuyer P.

J Proteomics. 2013 Jun 24;85:12-27. doi: 10.1016/j.jprot.2013.04.022. Epub 2013 Apr 24.

PMID:
23624238
17.

Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.

Prunotto M, Farina A, Lane L, Pernin A, Schifferli J, Hochstrasser DF, Lescuyer P, Moll S.

J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.

PMID:
23376485
18.

EasyProt--an easy-to-use graphical platform for proteomics data analysis.

Gluck F, Hoogland C, Antinori P, Robin X, Nikitin F, Zufferey A, Pasquarello C, Fétaud V, Dayon L, Müller M, Lisacek F, Geiser L, Hochstrasser D, Sanchez JC, Scherl A.

J Proteomics. 2013 Feb 21;79:146-60. doi: 10.1016/j.jprot.2012.12.012. Epub 2012 Dec 28.

PMID:
23277275
19.

Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application.

Lehmann S, Hoofnagle A, Hochstrasser D, Brede C, Glueckmann M, Cocho JA, Ceglarek U, Lenz C, Vialaret J, Scherl A, Hirtz C; IFCC Working Group on Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP).

Clin Chem Lab Med. 2013 May;51(5):919-35. doi: 10.1515/cclm-2012-0723. Review.

PMID:
23183755
20.

Blood glutathione S-transferase-π as a time indicator of stroke onset.

Turck N, Robin X, Walter N, Fouda C, Hainard A, Sztajzel R, Wagner G, Hochstrasser DF, Montaner J, Burkhard PR, Sanchez JC.

PLoS One. 2012;7(9):e43830. doi: 10.1371/journal.pone.0043830. Epub 2012 Sep 17.

21.

Electron transfer dissociation mass spectrometry of hemoglobin on clinical samples.

Coelho Graça D, Lescuyer P, Clerici L, Tsybin YO, Hartmer R, Meyer M, Samii K, Hochstrasser DF, Scherl A.

J Am Soc Mass Spectrom. 2012 Oct;23(10):1750-6. Epub 2012 Aug 7.

PMID:
22869297
22.

LC-MS (/MS) in clinical toxicology screening methods.

Viette V, Hochstrasser D, Fathi M.

Chimia (Aarau). 2012;66(5):339-42. doi: 10.2533/chimia.2012.339. Review.

PMID:
22867548
23.

Translational proteomics.

Lescuyer P, Bianchi L, Hochstrasser D, Bini L, Sanchez JC.

J Proteomics. 2012 Aug 3;75(15):4571-2. doi: 10.1016/j.jprot.2012.06.018. No abstract available.

PMID:
22828170
24.

Comparison of gel-based methods for the detection of cerebrospinal fluid rhinorrhea.

Lescuyer P, Auer L, Converset V, Hochstrasser DF, Landis BN, Burkhard PR.

Clin Chim Acta. 2012 Jul 11;413(13-14):1145-50. doi: 10.1016/j.cca.2012.03.016. Epub 2012 Mar 27.

PMID:
22483794
25.

Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease.

Licker V, Côte M, Lobrinus JA, Rodrigo N, Kövari E, Hochstrasser DF, Turck N, Sanchez JC, Burkhard PR.

J Proteomics. 2012 Aug 3;75(15):4656-67. doi: 10.1016/j.jprot.2012.02.032. Epub 2012 Mar 6.

PMID:
22410244
26.

The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome.

Paik YK, Jeong SK, Omenn GS, Uhlen M, Hanash S, Cho SY, Lee HJ, Na K, Choi EY, Yan F, Zhang F, Zhang Y, Snyder M, Cheng Y, Chen R, Marko-Varga G, Deutsch EW, Kim H, Kwon JY, Aebersold R, Bairoch A, Taylor AD, Kim KY, Lee EY, Hochstrasser D, Legrain P, Hancock WS.

Nat Biotechnol. 2012 Mar 7;30(3):221-3. doi: 10.1038/nbt.2152. No abstract available.

PMID:
22398612
27.

Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.

Pagano S, Satta N, Werling D, Offord V, de Moerloose P, Charbonney E, Hochstrasser D, Roux-Lombard P, Vuilleumier N.

J Intern Med. 2012 Oct;272(4):344-57. doi: 10.1111/j.1365-2796.2012.02530.x. Epub 2012 Mar 26.

28.

Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

Finckh A, Courvoisier DS, Pagano S, Bas S, Chevallier-Ruggeri P, Hochstrasser D, Roux-Lombard P, Gabay C, Vuilleumier N.

Arthritis Care Res (Hoboken). 2012 Jun;64(6):817-25. doi: 10.1002/acr.21631. Epub 2012 Feb 2.

29.

Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression.

Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, Ebeling M, Badi L, Reis B, Bitter H, D'Asaro M, Chiappe A, Sridhar S, Pacheco GD, Burczynski ME, Hochstrasser D, Vonderscher J, Matthes T.

PLoS One. 2012;7(1):e29979. doi: 10.1371/journal.pone.0029979. Epub 2012 Jan 20.

30.

Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.

Keller PF, Pagano S, Roux-Lombard P, Sigaud P, Rutschmann OT, Mach F, Hochstrasser D, Vuilleumier N.

J Intern Med. 2012 May;271(5):451-62. doi: 10.1111/j.1365-2796.2011.02479.x. Epub 2011 Nov 30.

31.

Temporal proteomic profiling of embryonic stem cell secretome during cardiac and neural differentiation.

Farina A, D'Aniello C, Severino V, Hochstrasser DF, Parente A, Minchiotti G, Chambery A.

Proteomics. 2011 Oct;11(20):3972-82. doi: 10.1002/pmic.201100063. Epub 2011 Sep 2.

PMID:
21770033
32.

The human proteome project: current state and future direction.

Legrain P, Aebersold R, Archakov A, Bairoch A, Bala K, Beretta L, Bergeron J, Borchers CH, Corthals GL, Costello CE, Deutsch EW, Domon B, Hancock W, He F, Hochstrasser D, Marko-Varga G, Salekdeh GH, Sechi S, Snyder M, Srivastava S, Uhlén M, Wu CH, Yamamoto T, Paik YK, Omenn GS.

Mol Cell Proteomics. 2011 Jul;10(7):M111.009993. doi: 10.1074/mcp.M111.009993.

33.

Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.

Nussbaumer S, Geiser L, Sadeghipour F, Hochstrasser D, Bonnabry P, Veuthey JL, Fleury-Souverain S.

Anal Bioanal Chem. 2012 Mar;402(8):2499-509. doi: 10.1007/s00216-011-5157-2. Epub 2011 Jun 24.

PMID:
21701850
34.

The human proteome project: Current state and future direction.

Legrain P, Aebersold R, Archakov A, Bairoch A, Bala K, Beretta L, Bergeron J, Borchers C, Corthals GL, Costello CE, Deutsch EW, Domon B, Hancock W, He F, Hochstrasser D, Marko-Varga G, Salekdeh GH, Sechi S, Snyder M, Srivastava S, Uhlen M, Hu CH, Yamamoto T, Paik YK, Omenn GS.

Mol Cell Proteomics. 2011 Apr 29. [Epub ahead of print]

35.

Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods.

Viette V, Fathi M, Rudaz S, Hochstrasser D, Veuthey JL.

Clin Chem Lab Med. 2011 Jul;49(7):1091-103. doi: 10.1515/CCLM.2011.182. Epub 2011 Apr 20. Review.

PMID:
21504375
36.

Qualitative and quantitative analysis of glycated proteins in human plasma by glucose isotopic labeling with ¹³C6-reducing sugars.

Priego-Capote F, Ramírez-Boo M, Hochstrasser D, Sanchez JC.

Methods Mol Biol. 2011;728:219-32. doi: 10.1007/978-1-61779-068-3_14.

PMID:
21468951
37.

Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts.

Cuoghi A, Farina A, Z'graggen K, Dumonceau JM, Tomasi A, Hochstrasser DF, Genevay M, Lescuyer P, Frossard JL.

J Proteome Res. 2011 May 6;10(5):2664-70. doi: 10.1021/pr2000557. Epub 2011 Apr 6.

PMID:
21425880
38.

A step further in the analysis of human bile proteome.

Farina A, Dumonceau JM, Delhaye M, Frossard JL, Hadengue A, Hochstrasser DF, Lescuyer P.

J Proteome Res. 2011 Apr 1;10(4):2047-63. doi: 10.1021/pr200011b. Epub 2011 Mar 4.

PMID:
21314112
39.

From relative to absolute quantification of tryptic peptides with tandem mass tags: application to cerebrospinal fluid.

Dayon L, Turck N, Scherl A, Hochstrasser DF, Burkhard PR, Sanchez JC.

Chimia (Aarau). 2010;64(3):132-5.

PMID:
21140904
40.

Shotgun proteomics: a relative quantitative approach using Off-Gel electrophoresis and LC-MS/MS.

Geiser L, Dayon L, Vaezzadeh AR, Hochstrasser DF.

Methods Mol Biol. 2011;681:459-72. doi: 10.1007/978-1-60761-913-0_27.

PMID:
20978983
41.

Shotgun proteomics: a qualitative approach applying isoelectric focusing on immobilized pH gradient and LC-MS/MS.

Geiser L, Vaezzadeh AR, Deshusses JM, Hochstrasser DF.

Methods Mol Biol. 2011;681:449-58. doi: 10.1007/978-1-60761-913-0_26.

PMID:
20978982
42.

Simultaneous quantification of ten cytotoxic drugs by a validated LC-ESI-MS/MS method.

Nussbaumer S, Fleury-Souverain S, Antinori P, Sadeghipour F, Hochstrasser DF, Bonnabry P, Veuthey JL, Geiser L.

Anal Bioanal Chem. 2010 Dec;398(7-8):3033-42. doi: 10.1007/s00216-010-4243-1. Epub 2010 Oct 7.

PMID:
20927508
43.

Proteomic analysis of heat shock-induced protection in acute pancreatitis.

Fetaud-Lapierre V, Pastor CM, Farina A, Hochstrasser DF, Frossard JL, Lescuyer P.

J Proteome Res. 2010 Nov 5;9(11):5929-42. doi: 10.1021/pr100695d. Epub 2010 Sep 23.

PMID:
20815342
44.

Recommendations for biomarker identification and qualification in clinical proteomics.

Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman RR, Ioannidis JP, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sánchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovski G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra TD, Weissinger E, Yamamoto T, Vlahou A.

Sci Transl Med. 2010 Aug 25;2(46):46ps42. doi: 10.1126/scitranslmed.3001249.

PMID:
20739680
45.

Urinary proteomics and drug discovery in chronic kidney disease: a new perspective.

Prunotto M, Ghiggeri GM, Candiano G, Lescuyer P, Hochstrasser D, Moll S.

J Proteome Res. 2011 Jan 7;10(1):126-32. doi: 10.1021/pr100464q. Epub 2010 Sep 2.

PMID:
20718506
46.

A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part II).

Viette V, Guillarme D, Mylonas R, Mauron Y, Fathi M, Rudaz S, Hochstrasser D, Veuthey JL.

Clin Biochem. 2011 Jan;44(1):45-53. doi: 10.1016/j.clinbiochem.2010.07.019. Epub 2010 Aug 10.

PMID:
20705066
47.

A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part I).

Viette V, Guillarme D, Mylonas R, Mauron Y, Fathi M, Rudaz S, Hochstrasser D, Veuthey JL.

Clin Biochem. 2011 Jan;44(1):32-44. doi: 10.1016/j.clinbiochem.2010.07.021. Epub 2010 Aug 4.

PMID:
20691172
48.

Is a gene-centric human proteome project the best way for proteomics to serve biology?

Rabilloud T, Hochstrasser D, Simpson RJ.

Proteomics. 2010 Sep;10(17):3067-72. doi: 10.1002/pmic.201000220.

49.

Analysis of the pancreatic low molecular weight proteome in an animal model of acute pancreatitis.

Lassout O, Pastor CM, Fétaud-Lapierre V, Hochstrasser DF, Frossard JL, Lescuyer P.

J Proteome Res. 2010 Sep 3;9(9):4535-44. doi: 10.1021/pr1002627.

PMID:
20604530
50.

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety.

Samer CF, Daali Y, Wagner M, Hopfgartner G, Eap CB, Rebsamen MC, Rossier MF, Hochstrasser D, Dayer P, Desmeules JA.

Br J Pharmacol. 2010 Jun;160(4):919-30. doi: 10.1111/j.1476-5381.2010.00709.x.

Supplemental Content

Loading ...
Support Center